Charles River Laboratories International Inc (NYSE:CRL) Share Price

Company Profile

Business description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact
251 Ballardvale Street
WilmingtonMA01887
USA
T: +1 781 222-6000
E: [email protected]
https://www.criver.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
20,100

Recommended

Earnings growth fails to excite investors worried about AI disruption.

Nathan Zaia | 25 February 2026

Impressive cost control and record production leads to higher dividend.

Mark Taylor | 25 February 2026

The market responded favourably to results but shares still underpriced.

Johannes Faul, CFA | 24 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,359.00	50.70	0.54%
CAC 40	8,544.55	25.34	0.30%
DAX 40	25,087.32	101.07	0.40%
Dow JONES (US)	49,174.50	370.44	0.76%
FTSE 100	10,786.21	105.62	0.99%
HKSE	26,765.72	175.40	0.66%
NASDAQ	22,863.68	236.41	1.04%
Nikkei 225	58,583.12	1,262.03	2.20%
NZX 50 Index	13,525.58	6.73	-0.05%
S&P 500	6,890.07	52.32	0.77%
S&P/ASX 200	9,128.30	44.20	0.49%
SSE Composite Index	4,147.23	29.82	0.72%